| Condition | DAAs | ADs | |||
| Follow-up | 2 yrs. n = 121 | 4 yrs. n = 99 | 6 yrs. n = 96 | Р | 1.5 - 9 yrs. n = 33 |
| Age, yrs. | 67 ± 0.77 | 66.6 ± 0.89 | 66.4 ± 0.87 | >0.05 | 58.6 ± 1.57 |
| M | 107% - 88.4% | 86% - 86.9% | 83% - 86.5% | >0.05 | 28% - 85% |
| F | 14% - 11.6% | 13% - 13.1% | 13% - 13.5% | >0.05 | 5% - 15% |
| AAAs | 91% - 75.2% | 76% - 76.8% | 75% - 78.1% | >0.05 |
|
| TAAs | 30% - 24.8% | 23% - 23.2% | 21% - 21.9% | >0.05 |
|
| d AAAs in mm | 43.97 ± 2.41 | 44.1 ± 1.7 | 44.36 ± 1.9 | >0.05 |
|
| d TAAs in mm | 48.88 ± 2.64 | 52.1 ± 2.6 | 52.01 ± 2.6 | >0.05 |
|
| Pts. with d < 50 mm | 70% - 57.8% | 66% - 66.7% | 65% - 67.7% | >0.05 | 23% - 69.7% |
| Pts. with d > 50 mm | 51% - 42.1% | 33% - 34% | 31% - 32.3% | >0.05 | 10% - 30.3% |
| Type I by DeBakey |
|
|
|
| 13% - 39% |
| Type IIIb by DeBakey |
|
|
|
| 20% - 61% |